Clinical trials
Cancer patients: population-based vs clinical trials
How performance status affects chemo outcomes
Surgery for advanced disease
FOLFOXIRI regimen: good survival, safe
Cure for initially unresectable CLM?
Effect of PVE on tumour growth rate
Survival after hepatic metastatectomy
Targeted therapy in advanced disease
Cetuximab + FOLFOX-4, KRAS mutational status
mCRC response to cetuximab + FOLFIRI
Panitumumab in first-line mCRC regimens?
Please login below to download this issue (PDF)